Nexcure Biologics Private Limited - Company Profile

It is a paper private limited company based in Dahisar West, Maharashtra, India, established in 2024.
2024 Dahisar West, Maharashtra, India Active
Last Updated:
About Nexcure Biologics Private Limited

Nexcure Biologics Private Limited, a active private limited company, was established on 19 November 2024 in Dahisar West, Maharashtra, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21001MH2024PTC435138. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Ratnesh Dharamchandra Jain (Director), Priyanjali Maria Dias (Director). Past directors included Prajakta Padmakar Dandekar. Its latest AGM occurred on 17 November 2025, with the balance sheet filed on 31 March 2025. It is based at A/203, Vithal Apts Chs Ltd,, Mitha Nagar Road,, Dahisar West, Maharashtra, 400068.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21001MH2024PTC435138

  • Registration Number

    435138

  • Incorporation Date

    19 November 2024

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 3 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Nexcure Biologics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nexcure Biologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nexcure Biologics Private Limited?
Current Directors
Name Designation Appointment Date Status
Ratnesh Dharamchandra Jain Director 19 Nov 2024 Current
Priyanjali Maria Dias Director 19 Nov 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Individual Subscriber - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nexcure Biologics.

Enhance accessibility to Nexcure Biologics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Nexcure Biologics revenue growth over time
Nexcure Biologics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nexcure Biologics?

Unlock access to Nexcure Biologics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Nexcure Biologics?

Unlock and access historical data on people associated with Nexcure Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nexcure Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexcure Biologics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nexcure Biologics
Recent Activity within the Organization
  • Annual General Meeting

    The activity Nexcure Biologics Private Limited last Annual general meeting of members was held on 17 Nov 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Nexcure Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Director Appointment

    The activity Ratnesh Dharamchandra Jain was appointed as a Director was appointed as a Director on 19 Nov 2024 & has been associated with this company since 1 year 3 months . was completed.

  • Director Appointment

    The activity Priyanjali Maria Dias was appointed as a Director was appointed as a Director on 19 Nov 2024 & has been associated with this company since 1 year 3 months . was completed.

  • Company Incorporation

    Progress on Nexcure Biologics Private Limited was registered on 19 Nov 2024 with Roc Mumbai & aged 1 year 3 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nexcure Biologics Private Limited?

The CIN of Nexcure Biologics Private Limited is U21001MH2024PTC435138.

Where is Nexcure Biologics Private Limited headquartered?

Nexcure Biologics Private Limited is headquartered at A/203, Vithal Apts Chs Ltd,, Mitha Nagar Road,, Dahisar West, Maharashtra, 400068.

When was Nexcure Biologics Private Limited incorporated?

Nexcure Biologics Private Limited was incorporated on 19 November 2024.

Who are the current directors of Nexcure Biologics Private Limited?

The current directors of Nexcure Biologics Private Limited are

What is the primary industry of Nexcure Biologics Private Limited?

The primary industry of Nexcure Biologics Private Limited is Paper.

Is Nexcure Biologics Private Limited a listed company?

Nexcure Biologics Private Limited is unlisted.

What is the capital structure of Nexcure Biologics Private Limited?

The authorized capital of Nexcure Biologics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available